kyvero
Market leaders

VEEV

Veeva Systems Inc. (VEEV)

Healthcare • Health Information Services

StockNYSEUnited StatesUS9224751084

302.42 USD -0.77% today Updated 13 Nov 2026 10:25

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Veeva Systems Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 10:25. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 25 Nov 2026 in 12 days · 16:00 · estimate 2.34
Last results 2.35 vs 2.22 estimated 26 Aug 2026 · Beat +5.8%
Beat the estimate 12 of 12 0 missed · 0 in line · 12 beats in a row
Average surprise +6.7% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

06 Dec 2023: estimate 1.29 06 Dec 2023: reported 1.34 12/23 29 Feb 2024: estimate 1.30 29 Feb 2024: reported 1.38 02/24 30 May 2024: estimate 1.42 30 May 2024: reported 1.50 05/24 28 Aug 2024: estimate 1.53 28 Aug 2024: reported 1.62 08/24 05 Dec 2024: estimate 1.58 05 Dec 2024: reported 1.75 12/24 05 Mar 2025: estimate 1.58 05 Mar 2025: reported 1.74 03/25 28 May 2025: estimate 1.74 28 May 2025: reported 1.97 05/25 27 Aug 2025: estimate 1.90 27 Aug 2025: reported 1.99 08/25 20 Nov 2025: estimate 1.95 20 Nov 2025: reported 2.04 11/25 04 Mar 2026: estimate 1.94 04 Mar 2026: reported 2.06 03/26 03 Jun 2026: estimate 2.14 03 Jun 2026: reported 2.24 06/26 26 Aug 2026: estimate 2.22 26 Aug 2026: reported 2.35 08/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
25 Nov 2026 16:00 2.34 — — Upcoming
26 Aug 2026 16:00 2.22 2.35 +5.8% Beat
03 Jun 2026 16:00 2.14 2.24 +4.9% Beat
04 Mar 2026 16:00 1.94 2.06 +6.5% Beat
20 Nov 2025 16:00 1.95 2.04 +4.6% Beat
27 Aug 2025 16:00 1.90 1.99 +4.8% Beat
28 May 2025 16:00 1.74 1.97 +13.0% Beat
05 Mar 2025 16:00 1.58 1.74 +10.1% Beat
05 Dec 2024 16:00 1.58 1.75 +10.7% Beat
28 Aug 2024 16:00 1.53 1.62 +5.6% Beat
30 May 2024 16:00 1.42 1.50 +5.3% Beat
29 Feb 2024 16:00 1.30 1.38 +6.2% Beat
06 Dec 2023 16:00 1.29 1.34 +3.7% Beat
30 Aug 2023 16:00 1.13 1.21 +7.3% Beat
31 May 2023 16:00 0.80 0.91 +13.6% Beat
01 Mar 2023 16:00 1.04 1.15 +10.6% Beat
01 Dec 2022 16:00 1.07 1.13 +5.3% Beat
31 Aug 2022 16:00 1.01 1.03 +2.0% Beat
01 Jun 2022 16:00 0.92 0.99 +7.3% Beat
02 Mar 2022 16:00 0.88 0.90 +2.0% Beat
01 Dec 2021 16:00 0.88 0.97 +10.6% Beat
01 Sep 2021 16:00 0.86 0.94 +9.0% Beat
27 May 2021 16:00 0.78 0.91 +16.7% Beat
02 Mar 2021 16:00 0.68 0.78 +14.5% Beat
01 Dec 2020 16:00 0.68 0.78 +14.8% Beat
27 Aug 2020 16:00 0.64 0.72 +12.7% Beat
28 May 2020 16:00 0.59 0.66 +12.5% Beat
03 Mar 2020 16:00 0.52 0.54 +3.6% Beat
26 Nov 2019 16:00 0.54 0.60 +10.2% Beat
27 Aug 2019 16:00 0.49 0.55 +12.1% Beat
29 May 2019 16:00 0.45 0.50 +12.0% Beat
26 Feb 2019 16:00 0.40 0.45 +11.8% Beat
28 Nov 2018 16:00 0.38 0.45 +18.1% Beat
23 Aug 2018 16:00 0.34 0.39 +15.9% Beat
24 May 2018 16:00 0.31 0.33 +8.1% Beat
27 Feb 2018 16:00 0.21 0.23 +7.8% Beat
05 Dec 2017 16:00 0.21 0.25 +17.0% Beat
24 Aug 2017 16:00 0.20 0.23 +15.2% Beat
25 May 2017 16:00 0.18 0.22 +21.7% Beat
28 Feb 2017 16:00 0.17 0.22 +28.2% Beat
22 Nov 2016 16:00 0.16 0.22 +40.6% Beat
30 Aug 2016 16:00 0.13 0.15 +15.0% Beat
26 May 2016 16:00 0.11 0.15 +35.2% Beat
01 Mar 2016 16:00 0.11 0.15 +37.1% Beat
24 Nov 2015 16:00 0.11 0.12 +12.7% Beat
27 Aug 2015 16:00 0.11 0.13 +20.5% Beat
28 May 2015 16:00 0.10 0.12 +20.3% Beat
03 Mar 2015 16:00 0.09 0.12 +35.1% Beat
25 Nov 2014 16:00 0.08 0.09 +14.1% Beat
28 Aug 2014 16:00 0.07 0.09 +30.9% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2026 3.2B +16.3% 908.9M 28.4% 5.44 +25.9% 1.4B
2025 2.7B +16.2% 714.1M 26.0% 4.32 +34.2% 1.1B
2024 2.4B +9.7% 525.7M 22.2% 3.22 +7.3% 911.3M
2023 2.2B — 487.7M 22.6% 3.00 — 780.5M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by day
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
12 Nov 2026 304.77 306.50 296.80 302.42 -0.77% 790,500
11 Nov 2026 309.93 311.38 304.74 304.77 -0.26% 1,042,100
10 Nov 2026 305.60 307.65 301.73 305.55 -0.28% 1,073,400
09 Nov 2026 303.93 308.21 300.59 306.40 +0.88% 1,232,500
06 Nov 2026 296.96 305.58 294.99 303.73 -2.05% 1,746,400
05 Nov 2026 312.89 314.23 305.17 310.10 -0.17% 2,149,700
04 Nov 2026 306.62 312.88 302.42 310.63 +2.45% 1,442,900
03 Nov 2026 303.00 306.55 299.02 303.21 -1.23% 1,419,600
02 Nov 2026 316.20 316.20 306.92 307.00 -1.90% 1,395,900
30 Oct 2026 312.06 314.50 309.42 312.96 +0.84% 1,374,800
1,251 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
304.77 USD
Market cap
49.0B
Exchange
NYSE
Country
United States
Sector
Healthcare
Industry
Health Information Services
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 24.2 / 25
  • Revenue growth of 14.0% a year
  • Earnings per share growth of 21.9% a year
Quality Return on equity, net margin and how stable the margins are. 19.3 / 25
  • ROE of 14%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 19.2 / 20
  • Net debt is -6.6× EBITDA
  • Free cash flow yield of 2.5%
Valuation Free cash flow yield and the P/E against its sector. 3.2 / 15
  • P/E 50.1 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price. 5.6 / 10
  • Analysts' target is +7% from the price

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 50.09× Weak 30.56×
P/E (forward) 29.78× Weak 14.16×
Price / book 6.65× Weak 3.5×
Price / sales 14.31× Weak 3.33×
EV / EBITDA 39.54× Weak 11.19×
Free cash flow yield 2.5% Fair 2.1%
Quality
FigureValueReading Sector median
Gross margin 75% Good 54.9%
Operating margin 29.6% Good 5.8%
Net margin 29.3% Good 1.2%
Return on equity 14.4% Fair 4.4%
Return on assets 7.6% Good 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year 14% Good 10.1%
EPS growth / year 21.9% Good 10.2%
Financial health
FigureValueReading Sector median
Debt / equity 0.02× Good 0.4×
Net debt / EBITDA -6.59× Good 1.46×
Current ratio 5.46× Good 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow VEEV and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in